Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Manouk Insider Profile
4 Followers
Anthony Manouk, Vice-President & General Counsel at Cannara Biotech, holds 4.40K shares in Cannara Biotech (Ticker: LOVFF). Most recently, Anthony Manouk Bought $4,400 shares of Cannara Biotech on May 25, 2024 for an estimated value of 3.26K.
Anthony Manouk has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Anthony Manouk's holdings
Insider Roles
Vice-President & General Counsel
Roles that Anthony Manouk holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Anthony Manouk
Anthony Manouk's Trading History
List of latest transactions for each holding click on a transaction to see Anthony Manouk's performance on stock
You May Also Like
Anthony Manouk insider profile FAQ
What is the percentage of profitable transactions made by Anthony Manouk?
The percentage of profitable transactions made by Anthony Manouk is ―.
What is the average return per transaction made by Anthony Manouk?
The average return per transaction made by Anthony Manouk is ―.
What stocks does Anthony Manouk hold?
Anthony Manouk holds: LOVFF stocks.
What was Anthony Manouk’s latest transaction?
Anthony Manouk latest transaction was an Informative Buy of $3.26K.
What was Anthony Manouk's most profitable transaction?
Anthony Manouk’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Anthony Manouk's role in Cannara Biotech?
Anthony Manouk's role in Cannara Biotech is Vice-President & General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.